Article Details

Roche's ENSPRYNG approved by European Commission as first and only at-home subcutaneous ...

Retrieved on: 2021-06-28 06:00:00

Tags for this article:

Click the tags to see associated articles and topics

Roche's ENSPRYNG approved by European Commission as first and only at-home subcutaneous .... View article details on HISWAI: https://www.globenewswire.com/news-release/2021/06/28/2253565/0/en/Roche-s-ENSPRYNG-approved-by-European-Commission-as-first-and-only-at-home-subcutaneous-treatment-for-neuromyelitis-optica-spectrum-disorder-NMOSD.html

Excerpt

Roche's ENSPRYNG approved by European Commission as first and only at-home subcutaneous treatment for neuromyelitis optica spectrum disorder ( ...

Article found on: www.globenewswire.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up